- Home
- CLRB vs WKSP Comparison
CLRB vs WKSP Comparison
Compare CLRB & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- WKSP
- Stock Information
- Founded
- CLRB 2002
- WKSP 2003
- Country
- CLRB United States
- WKSP United States
- Employees
- CLRB N/A
- WKSP N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- CLRB Health Care
- WKSP Consumer Discretionary
- Exchange
- CLRB Nasdaq
- WKSP Nasdaq
- Market Cap
- CLRB 12.5M
- WKSP 14.7M
- IPO Year
- CLRB N/A
- WKSP N/A
- Fundamental
- Price
- CLRB $0.25
- WKSP $3.41
- Analyst Decision
- CLRB Hold
- WKSP Strong Buy
- Analyst Count
- CLRB 2
- WKSP 2
- Target Price
- CLRB N/A
- WKSP $15.75
- AVG Volume (30 Days)
- CLRB 729.7K
- WKSP 96.7K
- Earning Date
- CLRB 05-13-2025
- WKSP 05-15-2025
- Dividend Yield
- CLRB N/A
- WKSP N/A
- EPS Growth
- CLRB N/A
- WKSP N/A
- EPS
- CLRB N/A
- WKSP N/A
- Revenue
- CLRB N/A
- WKSP $8,484,379.00
- Revenue This Year
- CLRB N/A
- WKSP $227.66
- Revenue Next Year
- CLRB N/A
- WKSP $52.23
- P/E Ratio
- CLRB N/A
- WKSP N/A
- Revenue Growth
- CLRB N/A
- WKSP 454.67
- 52 Week Low
- CLRB $0.22
- WKSP $2.44
- 52 Week High
- CLRB $3.49
- WKSP $12.00
- Technical
- Relative Strength Index (RSI)
- CLRB 39.17
- WKSP 56.44
- Support Level
- CLRB $0.23
- WKSP $2.72
- Resistance Level
- CLRB $0.27
- WKSP $3.47
- Average True Range (ATR)
- CLRB 0.02
- WKSP 0.29
- MACD
- CLRB -0.00
- WKSP 0.13
- Stochastic Oscillator
- CLRB 15.12
- WKSP 88.17
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.